Advertisement

Journal of Neural Transmission

, Volume 118, Issue 4, pp 531–538 | Cite as

Down regulation of trophic factors in neonatal rat spinal cord after administration of cerebrospinal fluid from sporadic amyotrophic lateral sclerosis patients

  • P. Deepa
  • Neelam Shahani
  • Phalguni Anand Alladi
  • K. Vijayalakshmi
  • T. N. Sathyaprabha
  • A. Nalini
  • V. Ravi
  • T. R. Raju
Basic Neurosciences, Genetics and Immunology - Original Article

Abstract

Accumulating evidence supports neuroprotective role of trophic factors in amyotrophic lateral sclerosis (ALS). Previous studies from our laboratory report that the CSF of patients with sporadic ALS (ALS-CSF) induces degenerative changes in the rat spinal motor neurons and reactive astrogliosis in the surrounding gray matter. The present study was aimed to investigate if the ALS-CSF affected the expression of trophic factors namely, brain-derived neurotrophic factor (BDNF), fibroblast growth factor 2 (FGF2) and insulin-like growth factor 1 (IGF1) in the newborn rat spinal cords. ALS-CSF was intrathecally injected into the neonatal rats and the mRNA levels of the trophic factors were determined by quantitative real-time polymerase chain reaction. Here, we report significant down regulation in the gene expression of trophic factors for BDNF, FGF2 and IGF1. BDNF mRNA levels were found to be reduced by 6.8-fold in the ALS-CSF injected group compared to control groups. The levels of IGF1 and FGF2 mRNA were also decreased by 3.91- and 2.13-fold, respectively, in the ALS group. We further found that exogenous supplementation of BDNF considerably reduced the aberrant phosphorylation of neurofilaments, complementing our earlier findings of restored expression of voltage gated sodium channel. Reduced expression of trophic factors indicates an altered microenvironment of the motor neurons and could possibly be one of the contributing factors in the degeneration process.

Keywords

Sporadic ALS BDNF IGF1 FGF2 ALS-CSF Rat spinal cord 

Notes

Acknowledgments

This study was funded by Indian Council for Medical Research (ICMR), Govt of India. Ms. Deepa and Dr. Vijayalakshmi are supported by the senior research fellowship and research associate fellowship, respectively, of Council for Scientific and Industrial Research (CSIR), Govt of India.

References

  1. (No authors listed) (1999) A controlled trial of recombinant methionyl human BDNF in ALS: The BDNF Study Group (Phase III). Neurology 52:1427–1433Google Scholar
  2. Adem A, Ekblom J (1994) Insulin-like growth factor-1 receptors in human spinal cord: changes in amyotrophic lateral sclerosis. J Neural Transm Gen Sect 97:73–84PubMedCrossRefGoogle Scholar
  3. Alladi PA, Mahadevan A, Shankar SK, Raju TR, Muthane U (2010) Expression of GDNF receptors GFRα1 and RET is preserved in substantia nigra pars compacta of aging Asian Indians. J Chem Neuroanat 40(1):43–52PubMedCrossRefGoogle Scholar
  4. Anand P, Parrett A (1995) Regional changes of ciliary neurotrophic factor and nerve growth factor levels in post mortem spinal cord and cerebral cortex from patients with motor disease. Nat Med 1(2):168–172PubMedCrossRefGoogle Scholar
  5. Apfel SC (1999) Neurotrophic factors in the therapy of diabetic neuropathy. Am J Med 107:34S–42SPubMedCrossRefGoogle Scholar
  6. Barde YA (1989) Trophic factors and neuronal survival. Neuron 6:1525–1534CrossRefGoogle Scholar
  7. Chiu AY, Chen EW, Lorea S (1994) Distinct neurotrophic responses of axotomized motor neurons to BDNF and CNTF in adult rats. Neuroreport 6:693–696CrossRefGoogle Scholar
  8. Cuevas P, Carceller F, Giménez-Gallego G (1995) Acidic fibroblast growth factor prevents post-axotomy neuronal death of the newborn rat facial nerve. Neurosci Lett 197:183–186PubMedCrossRefGoogle Scholar
  9. Dolcet X, Egea J, Soler RM, Martin Zanca D, Comella JX (1999) Activation of phosphatidylinositol 3-kinase, but not extracellular-regulated kinases is necessary to mediate brain-derived neurotrophic factor-induced motoneuron survival. J Neurochem 73:521–531PubMedCrossRefGoogle Scholar
  10. Doré S, Kar S, Quirion R (1997) Re-discovering an old friend, IGF-I: potential use in the treatment of neurodegenerative diseases. Trends Neurosci 20:326–331PubMedCrossRefGoogle Scholar
  11. Eagleson KL, Raju TR, Bennet MR (1985) Motoneurone survival is induced by immature astrocytes from developing avian spinal cord. Brain Res 349(1–2):95–104PubMedGoogle Scholar
  12. Ekestern E (2004) Neurotrophic factors and amyotrophic lateral sclerosis. Neurodegener Dis 1:88–100PubMedCrossRefGoogle Scholar
  13. Ghosh A, Carnahan J, Greenberg ME (1994) Requirement for BDNF in activity-dependent survival of cortical neurons. Science 263:1618–1623PubMedCrossRefGoogle Scholar
  14. Grothe C, Wewetzer K, Lagrange A, Unsicker K (1991) Effects of basic fibroblast growth factor on survival and choline acetyltransferase development of spinal cord neurons. Brain Res Dev Brain Res 62:257–261PubMedCrossRefGoogle Scholar
  15. Gunasekaran R, Narayani RS, Vijayalakshmi K, Alladi PA, Shobha K, Nalini A, Sathyaprabha TN, Raju TR (2009) Exposure to cerebrospinal fluid of sporadic amyotrophic lateral sclerosis patients alters Nav1.6 and Kv1.6 channel expression in rat spinal motor neurons. Brain Res 1255:170–179PubMedCrossRefGoogle Scholar
  16. Hetman M, Cavanaugh JE, Kimelman D, Xia Z (2000) Role of glycogen synthase kinase-3 beta in neuronal apoptosis induced by trophic withdrawal. J Neurosci 20:2567–2574PubMedGoogle Scholar
  17. Hughes RA, Sendtner M, Goldfarb M, Lindholm D, Thoenen H (1993) Evidence that fibroblast growth factor 5 is a major muscle-derived survival factor for cultured spinal motoneurons. Neuron 10:369–377PubMedCrossRefGoogle Scholar
  18. Ikeda K, Iwasaki Y, Tagaya N, Shiojima T, Kobayashi T, Kinoshita M (1995) Neuroprotective effect of basic fibroblast growth factor on wobbler mouse motor neuron disease. Neurol Res 17:445–448PubMedGoogle Scholar
  19. Ishiyama T, Ogo H, Wongc V, Klinkosza B, Noguchib H, Nakayamab C, Mitsumoto H (2002) Methionine-free brain-derived neurotrophic factor in wobbler mouse motor neuron disease: dose-related effects and comparison with the methionyl form. Brain Res 944:195–199PubMedCrossRefGoogle Scholar
  20. Kage M, Yang Q, Yang Q, Sato H, Matsumoto S, Kaji R, Akiguchi I, Kimura H, Tooyama I (2001) Acidic fibroblast growth factor (FGF-1) in the anterior horn cells of ALS and control cases. Neuroreport 12:3799–3803PubMedCrossRefGoogle Scholar
  21. Kaspar B, Llado KJ, Sherkat N, Rothstein JD, Gage FH (2003) Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model. Science 301:839–842PubMedCrossRefGoogle Scholar
  22. Kishino A, Ishige Y, Tatsuno T, Nakayama C, Noguchi H (1997) BDNF prevents and reverses adult rat motor neuron degeneration and induces axonal outgrowth. Exp Neurol 144:273–286PubMedCrossRefGoogle Scholar
  23. Lewis ME, Neff NT, Contrera PC, Stong DB, Oppenheim RW, Grebow PE, Vaught JL (1993) Insulin-like growth factor-I: potential for treatment of motor neuronal disorders. Exp Neurol 124:73–88PubMedCrossRefGoogle Scholar
  24. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:402–408PubMedCrossRefGoogle Scholar
  25. Maisonpierre P, Belluscio CL, Friedman B, Alderson RF, Wiegand SJ, Furth ME, Lindsay RM, Yancopoulos GD (1990) NT-3, BDNF, and NGF in the developing rat nervous system: parallel as well as reciprocal patterns of expression. Neuron 5:501–509PubMedCrossRefGoogle Scholar
  26. Mitsumoto H, Tsuzaka K (1999) Neurotrophic factors and neuro-muscular disease: II. GDNF, other neurotrophic factors, and future directions. Muscle Nerve 22:1000–1021PubMedCrossRefGoogle Scholar
  27. Nishio T, Sunohara N, Furukawa S (1998) Neutrophin switching in spinal motoneurons of amyotrophic lateral sclerosis. Neuroreport 9:1661–1665PubMedCrossRefGoogle Scholar
  28. Oppenheim RW, Yin QW, Prevette D, Yan Q (1992) Brain-derived neurotrophic factor rescues developing avian motoneurons from cell death. Nature 360:755–757PubMedCrossRefGoogle Scholar
  29. Rao MS, Devi MG, Nalini A, Shahani N, Raju TR (1995) Neurofilament phosphorylation is increased in ventral horn neurons of neonatal rat spinal cord exposed to cerebrospinal fluid from patients with amyotrophic lateral sclerosis. Neurodegeneration 4:397–401PubMedCrossRefGoogle Scholar
  30. Rothstein JD (1996) Excitotoxicity hypothesis. Neurology 47:S19–S25 (discussion S26)PubMedGoogle Scholar
  31. Rowland LP (2000) Six important themes in amyotrophic lateral sclerosis (ALS) research. J Neurol Sci 180:2–6PubMedCrossRefGoogle Scholar
  32. Schecterson LC, Bothwell M (1992) Novel roles for neurotrophins are suggested by BDNF and NT-3 mRNA expression in developing neurons. Neuron 9:449–463PubMedCrossRefGoogle Scholar
  33. Scicchitano BM, Rizzuto E, Musarò A (2009) Counteracting muscle wasting in aging and neuromuscular diseases: the critical role of IGF-1. Aging (Albany NY) 1:451–457Google Scholar
  34. Segal RA, Greenberg ME (1996) Intracellular signaling pathways activated by neurotrophic factors. Annu Rev Neurosci 19:463–489PubMedCrossRefGoogle Scholar
  35. Sendtner M, Holtmann B (1992) Brain-derived neurotrophic factor prevents the death of motoneurons in newborn rats after nerve section. Nature 360:757–759PubMedCrossRefGoogle Scholar
  36. Shahani N, Nalini A, Gourie-Devi M, Raju TR (1998) Reactive astrogliosis in neonatal rat spinal cord after exposure to cerebrospinal fluid from patients with amyotrophic lateral sclerosis. Exp Neurol 149:295–298PubMedCrossRefGoogle Scholar
  37. Shobha K, Vijayalakshmi K, Alladi PA, Nalini A, Sathyaprabha TN, Raju TR (2007) Altered in vitro and in vivo expression of glial glutamate transporter-1 following exposure to cerebrospinal fluid of amyotrophic lateral sclerosis patients. J Neurol Sci 254:9–16PubMedCrossRefGoogle Scholar
  38. Shobha K, Alladi PA, Nalini A, Raju TR, Sathyaprabha TN (2010) Exposure to CSF from sporadic amyotrophic lateral sclerosis patients induces morphological transformation of astroglia and enhances GFAP and S100beta expression. Neurosci Lett 473:56–61PubMedCrossRefGoogle Scholar
  39. Strong MJ (2003) The basic aspects of therapeutics in amyotrophic lateral sclerosis. Pharmacol Ther 98:379–414PubMedCrossRefGoogle Scholar
  40. Vijayalakshmi K, Alladi PA, Sathyaprabha TN, Subramaniam JR, Nalini A, Raju TR (2009) Cerebrospinal fluid from sporadic amyotrophic lateral sclerosis patients induces degeneration of a cultured motor neuron cell line. Brain Res 1263:122–133PubMedCrossRefGoogle Scholar
  41. Vincent AM, Mobley BC (2004) IGF-I prevents glutamate-induced motor neuron programmed cell death. Neurobiol Dis 16:407–416PubMedCrossRefGoogle Scholar
  42. Wong V, Arriaga R, Ip NY, Lindsay RM (1993) The neurotrophins BDNF, NT-3 and NT-4/5, but not NGF, up-regulate the cholinergic phenotype of developing motor neurons. Eur J Neurosci 5:466–474PubMedCrossRefGoogle Scholar
  43. Yan Q, Elliott J (1992) Brain-derived neurotrophic factor rescues spinal motor neurons from axotomy-induced cell death. Nature 360:753–755PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2010

Authors and Affiliations

  • P. Deepa
    • 1
  • Neelam Shahani
    • 1
    • 4
  • Phalguni Anand Alladi
    • 1
  • K. Vijayalakshmi
    • 1
  • T. N. Sathyaprabha
    • 1
  • A. Nalini
    • 3
  • V. Ravi
    • 2
  • T. R. Raju
    • 1
  1. 1.Department of NeurophysiologyNational Institute of Mental Health and NeurosciencesBangaloreIndia
  2. 2.Department of NeurovirologyNational Institute of Mental Health and NeurosciencesBangaloreIndia
  3. 3.Department of NeurologyNational Institute of Mental Health and NeurosciencesBangaloreIndia
  4. 4.Graduate Program in Cellular and Molecular Medicine, Department of NeuroscienceJohns Hopkins University School of MedicineBaltimoreUSA

Personalised recommendations